Entity family
Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.
Showing 781–840 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
…serves in an advisory capac. J. Fiehler: 2; C; Funding from the European Commission; personal consulting fees from Acandis, Cerenovus, Medtronic, M…
…pping. Insurance status demonstrated modality-specific effects: Medicare insurance was associated with increased mortality and complicat…
…Introduction The Subdural Evacuating Port System (SEPS; Medtronic, Galway, Ireland) is a widely utilized minimally invasive appro…
…ry 2026 was conducted using PubMed, Scopus, Web of Science, and Embase in accordance with PRISMA guidelines.Results Forty-one patients…
…ance or preventive interventions.Disclosures M. McIntyre: 1; C; The Aneurysm & AVM Foundation. D. Lakhani: None. A. Malhotra: None.…
…vascular therapy in optimizing cSDH resolution.Acknowledgements The Segal Family Foundation provides grant support for the Segal Family Internship in Cereb…
…modification across 12 variables. The study was registered with PROSPERO (CRD420261297405).Results Twenty-six studies including 12,601 p…
…or adequate care. RAPID SDH (iSchemaView, Menlo Park, CA) is an FDA-cleared, fully automated artificial intelligence platform designed to d…
… W. Guerrero: None. M. Mokin: 2; C; Medtronic, Imperative Care, Balt USA, Microvention, Rapid Pulse. K. Vakharia: 2; C; Medtronic, Terum…
…tical coherence tomography (nOCT) has begun clinical trials for FDA clearance. However, registration of these high-resolution data …
…ered within 4.5 hours of stroke symptoms. Tenecteplase (TNK) is FDA-approved for STEMI, but its off-label use for AIS is rising due to its g…
…Europe, multicenter, prospective, randomized, blinded endpoint, FDA IDE trial in patients ineligible for IV thrombolysis. Trial obj…